Indicator development programme
Closed for comments This consultation ended on at Request commenting lead permission
Contents
Pain: strong opioid use (osteoarthritis and chronic low back pain) 4
Pain: strong opioid use (MSK) 6
Pain: annual review long term opioid use 8
Diabetes: metformin and SGLT2 inhibitors (T2DM) 10
Diabetes: metformin and SGLT2 inhibitors (early onset T2DM) 12
Diabetes: metformin, SGLT2 inhibitors and semaglutide (T2DM and CVD) 14
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions